135 filings
424B5
IKT
Inhibikase Therapeutics Inc
22 May 24
Prospectus supplement for primary offering
8:55am
8-K
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
424B5
IKT
Inhibikase Therapeutics Inc
20 May 24
Prospectus supplement for primary offering
7:09am
10-Q
2024 Q1
IKT
Inhibikase Therapeutics Inc
Quarterly report
15 May 24
5:04pm
RW
IKT
Inhibikase Therapeutics Inc
15 May 24
Registration withdrawal request
7:56am
8-K
1lpql
30 Apr 24
Regulation FD Disclosure
8:17am
DEFA14A
zy7vql5la 0ee
26 Apr 24
Additional proxy soliciting materials
4:30pm
ARS
itqof
26 Apr 24
Annual report to shareholders
4:20pm
8-K
v25m0
18 Apr 24
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
9:46pm
8-K/A
0ppq vijqwx6t8v4c1
2 Apr 24
Departure of Directors or Certain Officers
5:12pm
8-K
bux x42agkdlwi8524y9
7 Feb 24
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA
7:59am
424B5
gwr9keeo
1 Feb 24
Prospectus supplement for primary offering
4:49pm